FDA issued a Warning Letter to Amgen, Inc. on 5/9/2003 for a previous inspection.
483 Amgen Mar 2013

483 Amgen Mar 2013

Erika Butler FDA, Steven Madzo FDA, Zachary Stamm FDA$119.00 - Available Now

FDA investigators audited the Amgen - Boulder, CO, United States facility and issued inspectional observations (via FDA 483) on 29 Mar 2013.

Product details

  • Category: Human Drugs
  • Inspection end: 29 Mar 2013
  • Location: Boulder, United States
  • FEI: 3003072024
Add To Cart